Gemcitabine, Paclitaxel, Doxorubicin, and Pegfilgrastim in Treating Patients With Metastatic or Unresectable Bladder Cancer or Urinary Tract Cancer and Kidney Dysfunction

This study is ongoing, but not recruiting participants.

Study NCT00478361 Information provided by National Cancer Institute (NCI)

First Received: May 23, 2007 Last Updated: May 13, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	April 2009 (Final data collection date for primary outcome measure)